CVE-2020-10936

CVE-2020-10936 is a high-severity vulnerability in Sympa with a CVSS 3.x base score of 7.8. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-269.

Key facts

Description

Sympa before 6.2.56 allows privilege escalation.

Frequently asked questions

What is CVE-2020-10936?
Sympa before 6.2.56 allows privilege escalation.
How severe is CVE-2020-10936?
CVE-2020-10936 has a CVSS 3.x base score of 7.8, rated high severity. It is exploitable over local access with low attack complexity, requires low privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.
Is CVE-2020-10936 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (39th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2020-10936?
CVE-2020-10936 primarily affects Sympa. In total, 6 product configurations (CPEs) are listed as vulnerable; see the affected-products list for the exact versions.
How do I fix CVE-2020-10936?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.
When was CVE-2020-10936 published?
CVE-2020-10936 was published on 2020-05-27 and last updated on 2026-06-17.

References

Affected products (6)

More vulnerabilities in Sympa

All CVEs affecting Sympa →

Other CWE-269 (Improper Privilege Management) vulnerabilities

Browse all CWE-269 (Improper Privilege Management) vulnerabilities →